Dr. Michael Dibella, MD

NPI: 1760471072
Total Payments
$3,180
2024 Payments
$319.85
Companies
19
Transactions
153
Medicare Patients
1,110
Medicare Billing
$81,880

Payment Breakdown by Category

Food & Beverage$3,092 (97.2%)
Education$88.32 (2.8%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,092 151 97.2%
Education $88.32 2 2.8%

Top Paying Companies

Company Total Records Latest Year
Amgen Inc. $597.51 36 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $560.46 32 $0 (2024)
LANTHEUS MEDICAL IMAGING, INC. $515.23 23 $0 (2024)
Janssen Pharmaceuticals, Inc $310.72 15 $0 (2023)
SANOFI-AVENTIS U.S. LLC $249.96 2 $0 (2018)
AstraZeneca Pharmaceuticals LP $232.43 14 $0 (2023)
Astellas Pharma US Inc $220.31 4 $0 (2022)
Gilead Sciences, Inc. $109.65 8 $0 (2019)
CSL Behring $80.00 1 $0 (2024)
E.R. Squibb & Sons, L.L.C. $66.56 4 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $319.85 14 Amgen Inc. ($93.67)
2023 $319.15 16 Amgen Inc. ($110.80)
2022 $456.02 18 Janssen Pharmaceuticals, Inc ($165.52)
2021 $33.13 2 Janssen Pharmaceuticals, Inc ($33.13)
2020 $97.50 4 Lantheus Medical Imaging, Inc. ($70.85)
2019 $344.52 18 Astellas Pharma US Inc ($98.28)
2018 $777.44 38 Lantheus Medical Imaging, Inc. ($197.52)
2017 $832.77 43 Lantheus Medical Imaging, Inc. ($180.76)

All Payment Transactions

153 individual payment records from CMS Open Payments — Page 1 of 7

Date Company Product Nature Form Amount Type
12/06/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $21.11 General
Category: Cardiology
11/18/2024 SCPHARMACEUTICALS INC. FUROSCIX (Drug) Food and Beverage In-kind items and services $17.15 General
Category: Cardiology
10/30/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $18.45 General
Category: DIABETES
09/05/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $17.41 General
Category: DIABETES
08/02/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $15.58 General
Category: Cardiology
06/27/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $22.96 General
Category: Cardiology
06/13/2024 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $14.32 General
Category: Cardiovascular
05/01/2024 LANTHEUS MEDICAL IMAGING, INC. DEFINITY (Drug) Food and Beverage In-kind items and services $21.05 General
Category: CONTRAST AGENT
04/25/2024 PFIZER INC. VYNDAQEL (Drug) Food and Beverage In-kind items and services $23.67 General
Category: CARDIOVASCULAR
04/15/2024 CSL Behring Kcentra (Biological) Education In-kind items and services $80.00 General
Category: Trauma (Emergency, Injury, Surgery)
04/15/2024 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $15.46 General
Category: Cardiovascular
03/27/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $16.61 General
Category: Cardiology
02/29/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $18.67 General
Category: DIABETES
02/21/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $17.41 General
Category: Cardiology
12/08/2023 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $17.32 General
Category: Cardiology
10/12/2023 Lantheus Medical Imaging, Inc. DEFINITY (Drug) Food and Beverage In-kind items and services $17.77 General
Category: CONTRAST AGENT
09/11/2023 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $25.72 General
Category: Cardiovascular
08/23/2023 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $21.64 General
Category: Cardiology
07/25/2023 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $14.96 General
Category: DIABETES
07/18/2023 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $26.48 General
Category: Cardiology
07/12/2023 Lexicon Pharmaceuticals, Inc. Inpefa (Drug) Food and Beverage In-kind items and services $17.44 General
Category: Inhibitor of SGLT2 and SGLT1
06/19/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $20.08 General
Category: Cardiovascular & Metabolism
05/10/2023 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $14.58 General
Category: DIABETES
05/02/2023 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $22.08 General
Category: Cardiology
04/20/2023 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $18.49 General
Category: DIABETES

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 155 162 $66,566 $13,239
2022 4 284 306 $110,130 $23,220
2021 4 229 242 $91,945 $19,841
2020 6 442 466 $144,278 $25,581
Total Patients
1,110
Total Services
1,176
Medicare Billing
$81,880
Procedure Codes
18

All Medicare Procedures & Services

18 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99285 Emergency department visit with high level of medical decision making Facility 2023 50 56 $34,918 $6,712 19.2%
99284 Emergency department visit with moderate level of medical decision making Facility 2023 53 53 $21,912 $4,491 20.5%
99283 Emergency department visit with low level of medical decision making Facility 2023 27 28 $6,044 $1,236 20.5%
99282 Emergency department visit with straightforward medical decision making Facility 2023 25 25 $3,691 $799.75 21.7%
99285 Emergency department visit for life threatening or functioning severity Facility 2022 108 114 $77,406 $16,446 21.2%
99284 Emergency department visit for problem of high severity Facility 2022 35 36 $16,537 $3,234 19.6%
99283 Emergency department visit for problem of moderate severity Facility 2022 52 53 $12,685 $2,923 23.0%
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only Facility 2022 89 103 $3,502 $616.02 17.6%
99285 Emergency department visit, problem with significant threat to life or function Facility 2021 89 91 $61,789 $13,326 21.6%
99284 Emergency department visit, problem of high severity Facility 2021 40 40 $18,440 $3,877 21.0%
99283 Emergency department visit, moderately severe problem Facility 2021 37 38 $9,234 $2,198 23.8%
93010 Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report Facility 2021 63 73 $2,482 $440.20 17.7%
99285 Emergency department visit, problem with significant threat to life or function Facility 2020 119 123 $93,681 $16,843 18.0%
99284 Emergency department visit, problem of high severity Facility 2020 46 49 $23,201 $3,950 17.0%
99283 Emergency department visit, moderately severe problem Facility 2020 53 55 $16,359 $2,000 12.2%
93016 Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision Facility 2020 74 74 $3,478 $1,307 37.6%
93018 Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report Facility 2020 74 74 $4,070 $873.12 21.5%
93010 Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report Facility 2020 76 91 $3,490 $607.77 17.4%

About Dr. Michael Dibella, MD

Dr. Michael Dibella, MD is a Emergency Medicine healthcare provider based in Buffalo, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1760471072.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Dibella, MD has received a total of $3,180 in payments from pharmaceutical and medical device companies, with $319.85 received in 2024. These payments were reported across 153 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,092).

As a Medicare-enrolled provider, Dibella has provided services to 1,110 Medicare beneficiaries, totaling 1,176 services with total Medicare billing of $81,880. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.

Practice Information

  • Specialty Emergency Medicine
  • Location Buffalo, NY
  • Active Since 10/19/2005
  • Last Updated 01/31/2018
  • Taxonomy Code 207P00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1760471072

Products in Payments

  • Repatha (Biological) $471.65
  • Definity (Drug) $405.56
  • XARELTO (Drug) $310.72
  • PRADAXA (Drug) $304.85
  • JARDIANCE (Drug) $255.61
  • PRALUENT (Drug) $249.96
  • BRILINTA (Drug) $216.11
  • Corlanor (Drug) $125.86
  • LEXISCAN (Drug) $112.17
  • DEFINITY (Drug) $109.67
  • Kcentra (Biological) $80.00
  • ENTRESTO (Drug) $59.18
  • ELIQUIS (Drug) $40.84
  • LifeVest (Device) $37.44
  • BIOMONITOR (Device) $34.50
  • CAMZYOS (Drug) $25.72
  • Lexiscan (Drug) $23.67
  • VYNDAQEL (Drug) $23.67
  • Inpefa (Drug) $17.44
  • FUROSCIX (Drug) $17.15

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Emergency Medicine Doctors in Buffalo